Literature DB >> 26107671

Intravoxel Incoherent Motion MR Imaging: Comparison of Diffusion and Perfusion Characteristics for Differential Diagnosis of Soft Tissue Tumors.

Jun Du1, Kun Li, Weisheng Zhang, Shaowu Wang, Qingwei Song, Ailian Liu, Yanwei Miao, Zhijin Lang, Lina Zhang, Minting Zheng.   

Abstract

We used intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) to explore the possibility of preoperative diagnosis of soft tissue tumors (STTs). This prospective study enrolled 23 patients. Conventional MRI and IVIM examinations were performed on a 3.0T MR imager. Eight (35%) hemangiomas, 11 (47%) benign soft tissue tumors excluding hemangiomas (BSTTEHs) and 4 soft tissue sarcomas (STSs) were assessed. The mean tumor size was about 1652.36 ± 233.66  mm(2). Ten b values (0-800  s/mm(2)) were used to evaluate diffusion and perfusion characteristics of IVIM. IVIM parameters (ADC(standard), ADC(slow), ADC(fast), and f) of STTs were measured and evaluated for differentiating hemangiomas, BSTTEHs, and STSs. ADC(slow) and ADC(fast) value were different for hemangiomas, BSTTEHs, and STSs separately (P < 0.001, P < 0.001, and P = 0.001). ADC(slow), cut-off value smaller than 0.93 × 10(-3)  mm(2)/s, was the best parameter to differ STSs (0.689 ± 0.173 × 10 (-3)mm(2)/s) from hemangiomas (0.933 ± 0.237 × 10 (-3)mm(2)/s) and BSTTEHs (1.156 ± 0.120 × 10 (-3)mm(2)/s) (P = 0.001). ADC(slow) (0.93 × 10(-3)  mm(2)/s <cut-off value <0.96 × 10(-3)  mm(2)/s) was used to distinguish hemangiomas from BSTTs. There were significant difference among hemangiomas, BSTTEHs, and STSs (P = 0.014, P = 0.036, P < 0.001). The ADC(standard), ADC(fast), and f value were different (P < 0.05) for STSs (1.009 ± 0.177 × 10 (-3) mm(2)/s, 15.700 ± 1.992 × 10(-3)  mm(2)/s, 0.503 ± 0.068), hemangiomas (1.505 ± 0.226 × 10(-3)  mm(2)/s, 11.675 ± 0.456 × 10(-3)  mm(2)/s, 0.682 ± 0.060), and BSTTEHs (1.555 ± 0.176 × 10(-3)  mm(2)/s, 11.727 ± 0.686 × 10(-3)  mm(2)/s, 0.675 ± 0.054). And there was no significant difference for these 3 parameters between hemangiomas and BSTTEHs (P = 0.584, 0.907, and 0.798). IVIM may be of significant value for differential diagnosing hemangiomas, BSTTEHs, and STSs.

Entities:  

Mesh:

Year:  2015        PMID: 26107671      PMCID: PMC4504541          DOI: 10.1097/MD.0000000000001028

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


INTRODUCTION

Soft tissue tumors (STTs), putatively mesenchymal origin, are sporadic without a known pathogenesis or established risk factors. There is a rising incidence in recent years for benign soft tissue tumors (BSTTs) more than 300/100,000 and malignant ones around 5/100,000 per year.[1] In addition, STTs represent a striking range of morphologic diversity and multiple individual clinical symptoms among different types.[2] Differential diagnosis of benign tumors and malignant ones should be made for further treatment in clinic. Soft tissue sarcomas (STSs), as the main malignant tumors, occur at any age and account for only 21% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers.[3] It is difficult to make a prospectively preoperative diagnosis of different subtypes of STTs due to their complexity and rarity. Magnetic resonance imaging (MRI) is considered the first choice of imaging modality to evaluate STTs.[4] However, there still are lots of problems need to be dealt with. For example, BSTTs may achieve dedifferentiation and exhibit hybrid histologic characteristics of malignant propensity. In addition, hemangiomas, accounting for 7% of BSTTs,[5] show diffuse growth and easy to relapse, which is the main cause of clinical misdiagnosis as malignant tumor. It is reported that MR imaging cannot reliably distinguish benign and malignant lesions when radiologic evaluation is nonspecific.[6] The inhomogeneity of lesions on T2, the change from homogeneity on T1 to inhomogeneity on T2 sequence, and the involvement of bone or neurovascular structures are features that may be helpful in differential diagnosing benign from malignant soft tissue masses, while whether MRI can be used to differentiate benign from malignant ones is still controversial.[7] Intravoxel incoherent motion (IVIM) imaging is an extension of diffusion weighted imaging (DWI) that integrates the apparent diffusion coefficient (ADC) contains both perfusion and diffusion terms.[8] Diffusion and perfusion are physically and biologically different phenomena.[9] The diffusion property of tumor tissues largely depends on cell density, which may also be predictive features of malignancy in some types of tumors. Perfusion is an important phenomenon of many physiological or pathological processes.[8] It is reported that IVIM imaging may be helpful for differentiating benign and malignant salivary gland tumors.[10] Therefore, to estimate these 2 distinctive phenomena in tumor tissues may be helpful in the diagnosis of STTs before surgery. The purpose of the present study was to assess the IVIM parameters for differential diagnosing hemangiomas, benign soft tissue tumors excluding hemangiomas (BSTTEHs), and STSs.

PATIENTS AND METHODS

Patients

The study was approved by the Institutional Ethics Committee of First Affiliated Hospital of Dalian Medical University (Dalian, China). Thirty-one consecutive patients were enrolled in this study and inspected conventional MR and IVIM-MR examination with 3.0-T MR imager from October 2013 to October 2014. Eight of these patients were excluded for further analysis: 4 patients did not receive surgery and there were no pathological results available; 1 tumor in the upper limb was close to artery and the quality of image was very poor; and for other 3 patients, there were no sufficient regions of interest (ROI) areas for IVIM analysis. As a result, only 23 STTs were further analyzed. Primary sites and clinical data of these tumors (11 female, 12 male; average age, 44 years; age range 16–85 years) were described in Table 1.
TABLE 1

Primary Sites and Clinical Data of 23 Soft Tissue Tumors

Primary Sites and Clinical Data of 23 Soft Tissue Tumors

Conventional MR Imaging

MRI was performed using a 3.0-T MR imager (Signa, HDxt, 3.0 T; General Electric Healthcare, Milwaukee, WI) with surface coil (limbs with 3 inch coil, shoulder with shoulder coil or soft coil, and torso and hips with body coil). The conventional MR scanning sequences included spin echo (SE) T1WI (repetition time/echo time [TR/TE], 650 ms/min full; reconstruction matrix size, 288 × 224; slice thickness/slice spacing, 4–6 mm/0–1 mm), fast spin echo (FSE) T2WI (TR/TE, 3975 ms/68 ms; number of signals acquired, 4; reconstruction matrix size, 256 × 224; slice thickness/slice spacing, 4–6 mm/0–1 mm), fat suppression T2WI and PDWI (TR/TE, 2000 ms/42 ms; number of signals acquired, 3; reconstruction matrix size, 256 × 224; slice thickness/slice spacing, 4–6 mm/0–1 mm). If necessary, fat suppression T1WI was performed. Field of view (FOV), which could be changed according to the tumors’ size, was 15 to 40 cm with slice thickness 4 to 6 mm and space 0 to 1 mm.

IVIM MR Imaging

IVIM scan was performed using spin-echo echo-planar imaging (SE-EPI) sequence (TR/TE, 8000 ms/min; NEX, 8; reconstruction matrix size, 128 × 128; slice thickness, slice spacing, and FOV similar to conventional scan; 10 b values [0, 10, 20, 30, 50, 100, 200, 300, 500, and 800 s/mm2]). In order to eliminate the influence of the anisotropy for the IVIM signal and the numerical measurement, 3 in 1 was applied. All patients were fixed on bed to prevent the influence of movement. Based on IVIM theory, the bi-exponential model was expressed by the following equation:[11] where Sb is the signal intensity in the pixel with diffusion gradient b, S0 the signal intensity in the pixel without diffusion gradient (b of 0 s/mm2), f the fractional perfusion related to the microcirculation, ADCslow the true diffusion coefficient as reflected by pure molecular diffusion, and ADCfast is the pseudo-diffusion coefficient representing perfusion-related diffusion or incoherent microcirculation.

Dynamic Contrast-Enhanced MR Imaging

Dynamic contrast-enhanced MR imaging was performed using 2-dimensional fast spoiled gradient echo sequence (2D FSPGR). The contrast agent gadolinium-DTPA (Magnevist, Berlex, New Jersey) was injected as 0.l mmol/kg, and 2.5 mL/s. And 10 mL saline was additionally injected at the same velocity.

Regions of Interest (ROI)

ROI was placed on the parenchyma of each tumor in DWI. Large cystic or necrotic areas and large vessels were not included. The mean ROI area was about 15.0 ± 1.21 mm2. Three ROIs in each image and totally 9 ROIs in 3 consecutive images of IVIM were calculated for each patient. The different values (ADCstandard, ADCslow, ADCfast, and f) of STTs were measured in GE-ADW 4.4 workstation.

Statistical Analysis

Two independent-sample t-test was used for assessing ADCslow and ADCfast of hemangiomas, BSTTEHs, and STSs separately. One-way ANOVA and least significant difference (LSD) t-test were used for comparing IVIM parameters among the 3 types of STTs. Receiver operating characteristic (ROC) curves were generated with respective cut-off values determined to accommodate best diagnostic accuracy based on the Youden index. SPSS (version19.0, Chicago, IL) was used for statistical analysis. P values < 0.05 were considered significant for 2-tailed probability.

RESULTS

In total, ROIs from 8 hemangiomas, 11 BSTTEHs, and 4 STSs were evaluated. The mean tumor size (maximum tumor areas measured using axial contrast-enhanced MR images) was 1652.36 ± 233.66 mm2. ADCslow and ADCfast value were different among hemangiomas, BSTTEHs, and STSs separately (P < 0.001, P < 0.001, and P = 0.001). Each IVIM parameter (ADCstandard, ADCslow, ADCfast, and f) for STTs was significant difference (P < 0.001, P = 0.001, P < 0.001, and P < 0.001) (Table 2, Figures 3–5). Multiple comparisons of IVIM parameters between each index are summarized in Table 3. The ADCstandard, ADCfast, and f values of hemangiomas and STSs or BSTTEHs and STSs were significant difference (P < 0.05), while there was no significant difference for these 3 parameters between hemangiomas and BSTTEHs (P = 0.584, P = 0.907, and P = 0.798). The ADCslow values between hemangiomas and BSTTEHs, hemangiomas and STSs, and also BSTTEHs and STSs were significant difference (P = 0.014, P = 0.036, and P < 0.001).
TABLE 2

One-Way ANOVA Tests Differing IVIM Parameters Among Hemangiomas, BSTTEHs, and STSs

FIGURE 3

A 23-year-old female was diagnosed hemangioma (arrow) in the right brachialis. (A) Axial T1WI demonstrates a solid mass of intermediate signal intensity (SI) compared to adjacent muscles. (B) Axial T2WI shows a lobulated mass with high SI. (C) Contrast-enhanced T1WI image shows intense homogeneous enhancement with large internal vessels. Characteristic changes in intravoxel incoherent motion (IVIM) parameters: (D) Location maps of ROI1, ROI2, and ROI3 in the first sectional image. Images (E–H) show ADCstandard, ADCslow, ADCfast, and f value separately. (I) Location maps of ROI4, ROI5, and ROI6 in the second sectional image. ADCstandard, ADCslow, ADCfast, and f value were placed in (J–M) successively. (N) Location maps of ROI7, ROI8, and ROI9 in the third sectional image. ADCstandard, ADCslow, ADCfast, and f value were put in (O–R) in proper order. Mean value of ADCstandard is 0.00160 ± 0.000288 mm2/s, ADCslow 0.000943 ± 0.000448 mm2/s, ADCfast 0.0111 ± 0.00319 mm2/s, and f 0.725 ± 0.0827 from ROI1 to ROI9, accordingly.

TABLE 3

LSD t-tests of Multiple Comparison of IVIM Parameters Value Among Hemangiomas, BSTTEHs, and STSs

One-Way ANOVA Tests Differing IVIM Parameters Among Hemangiomas, BSTTEHs, and STSs LSD t-tests of Multiple Comparison of IVIM Parameters Value Among Hemangiomas, BSTTEHs, and STSs The ROC curves and optimal cut-off values of IVIM parameters were used to identify STSs from STTs (Figure 1 and Table 4). The ADCslow value was the most powerful parameter, with area under the curve of 0.86, followed by ADCstandard 0.72 and f 0.56. ADCfast was the least meaningful one with area 0.34. The ROC curve and optimal cut-off value of ADCslow were used to discriminate hemangiomas from BSTTs in Figure 2 and Table 5. The optimal cut-off value was between 0.93 × 10−3 and 0.96 × 10−3 mm2/s. Two steps to deal with STTs were indicated in Table 6. First step was to separate BSTTs (Figures 3 and 4) from STSs (Figure 5), and then to identify hemangiomas (Figure 3) from BSTTs.
FIGURE 1

ROC curves of IVIM parameters for identifying soft tissue sarcoma from hemangioma and benign tumors.

TABLE 4

Diagnostic Characteristics of IVIM Parameters to Identify STSs From STTs Based on the Respective Cut-Off Values

FIGURE 2

ROC curve of ADCslow for discriminating hemangioma from benign tumors.

TABLE 5

Diagnostic Characteristics of ADCslow to Discriminate Hemangiomas from BSTTs Based on the Respective Cut-Off Values

TABLE 6

Two Steps to Deal with STTs: Firstly, Differentiating BSTTs and STSs, and Then Identifying Hemangiomas From BSTTs

FIGURE 4

A 59-year-old male was diagnosed Schwannoma (arrow) in the subcutaneous fat of left knee between vastus medialis and sartorius. (A) Axial T1WI demonstrates a solid mass of intermediate signal intensity (SI). (B) Axial T2WI shows the ovoid mass with heterogeneously hyper SI. (C) Contrast-enhanced T1WI shows heterogeneously enhanced. Characteristic changes in IVIM parameters: (D) Location map of ROI1, ROI2, and ROI3 in the first sectional image. Images (E–H) separately show ADCstandard, ADCslow, ADCfast, and f value. (I) Location map of ROI4, ROI5, and ROI6 in the second sectional image. ADCstandard, ADCslow, ADCfast, and f value were placed in (J–M) successively. (N) Location maps of ROI7, ROI8, and ROI9 in the third sectional image. ADCstandard, ADCslow, ADCfast, and f value were put in (O–R) in proper order. Mean value of ADCstandard is 0.00168 ± 0.000129 mm2/s, ADCslow 0.00130 ± 0.000140 mm2/s, ADCfast 0.0108 ± 0.000380 mm2/s, and f 0.714 ± 0.0307 from ROI1 to ROI9, accordingly.

FIGURE 5

A 74-year-old female was diagnosed myxoid liposarcoma (arrow) in the subcutaneous fat of her right back. (A) Axial T1WI demonstrates a solid mass of low signal intensity (SI). (B) Axial T2WI shows a lobulated mass with high SI. (C) Contrast-enhanced T1WI shows heterogeneously enhanced solid tissues and thickened septa. Characteristic changes in IVIM parameters: (D) Location maps of ROI1, ROI2, and ROI3 in the first sectional image. Images (E–H) separately show ADCstandard, ADCslow, ADCfast, and f value. (I) Location maps of ROI4, ROI5, and ROI6 in the second sectional image. ADCstandard, ADCslow, ADCfast, and f value were placed in (J–M) successively. (N) Location maps of ROI7, ROI8, and ROI9 in the third sectional image. ADCstandard, ADCslow, ADCfast, and f value were put in (O–R) in proper order. Mean value of ADCstandard is 0.00118 ± 0.000134 mm2/s, ADCslow 0.000849 ± 0.000207 mm2/s, ADCfast 0.0140 ± 0.00344 mm2/s, and f 0.562 ± 0.0631 from ROI1 to ROI9, accordingly.

ROC curves of IVIM parameters for identifying soft tissue sarcoma from hemangioma and benign tumors. Diagnostic Characteristics of IVIM Parameters to Identify STSs From STTs Based on the Respective Cut-Off Values ROC curve of ADCslow for discriminating hemangioma from benign tumors. Diagnostic Characteristics of ADCslow to Discriminate Hemangiomas from BSTTs Based on the Respective Cut-Off Values Two Steps to Deal with STTs: Firstly, Differentiating BSTTs and STSs, and Then Identifying Hemangiomas From BSTTs A 23-year-old female was diagnosed hemangioma (arrow) in the right brachialis. (A) Axial T1WI demonstrates a solid mass of intermediate signal intensity (SI) compared to adjacent muscles. (B) Axial T2WI shows a lobulated mass with high SI. (C) Contrast-enhanced T1WI image shows intense homogeneous enhancement with large internal vessels. Characteristic changes in intravoxel incoherent motion (IVIM) parameters: (D) Location maps of ROI1, ROI2, and ROI3 in the first sectional image. Images (E–H) show ADCstandard, ADCslow, ADCfast, and f value separately. (I) Location maps of ROI4, ROI5, and ROI6 in the second sectional image. ADCstandard, ADCslow, ADCfast, and f value were placed in (J–M) successively. (N) Location maps of ROI7, ROI8, and ROI9 in the third sectional image. ADCstandard, ADCslow, ADCfast, and f value were put in (O–R) in proper order. Mean value of ADCstandard is 0.00160 ± 0.000288 mm2/s, ADCslow 0.000943 ± 0.000448 mm2/s, ADCfast 0.0111 ± 0.00319 mm2/s, and f 0.725 ± 0.0827 from ROI1 to ROI9, accordingly. A 59-year-old male was diagnosed Schwannoma (arrow) in the subcutaneous fat of left knee between vastus medialis and sartorius. (A) Axial T1WI demonstrates a solid mass of intermediate signal intensity (SI). (B) Axial T2WI shows the ovoid mass with heterogeneously hyper SI. (C) Contrast-enhanced T1WI shows heterogeneously enhanced. Characteristic changes in IVIM parameters: (D) Location map of ROI1, ROI2, and ROI3 in the first sectional image. Images (E–H) separately show ADCstandard, ADCslow, ADCfast, and f value. (I) Location map of ROI4, ROI5, and ROI6 in the second sectional image. ADCstandard, ADCslow, ADCfast, and f value were placed in (J–M) successively. (N) Location maps of ROI7, ROI8, and ROI9 in the third sectional image. ADCstandard, ADCslow, ADCfast, and f value were put in (O–R) in proper order. Mean value of ADCstandard is 0.00168 ± 0.000129 mm2/s, ADCslow 0.00130 ± 0.000140 mm2/s, ADCfast 0.0108 ± 0.000380 mm2/s, and f 0.714 ± 0.0307 from ROI1 to ROI9, accordingly. A 74-year-old female was diagnosed myxoid liposarcoma (arrow) in the subcutaneous fat of her right back. (A) Axial T1WI demonstrates a solid mass of low signal intensity (SI). (B) Axial T2WI shows a lobulated mass with high SI. (C) Contrast-enhanced T1WI shows heterogeneously enhanced solid tissues and thickened septa. Characteristic changes in IVIM parameters: (D) Location maps of ROI1, ROI2, and ROI3 in the first sectional image. Images (E–H) separately show ADCstandard, ADCslow, ADCfast, and f value. (I) Location maps of ROI4, ROI5, and ROI6 in the second sectional image. ADCstandard, ADCslow, ADCfast, and f value were placed in (J–M) successively. (N) Location maps of ROI7, ROI8, and ROI9 in the third sectional image. ADCstandard, ADCslow, ADCfast, and f value were put in (O–R) in proper order. Mean value of ADCstandard is 0.00118 ± 0.000134 mm2/s, ADCslow 0.000849 ± 0.000207 mm2/s, ADCfast 0.0140 ± 0.00344 mm2/s, and f 0.562 ± 0.0631 from ROI1 to ROI9, accordingly.

DISCUSSION

There are similar imaging characteristics (such as diffuse growth, easy to relapse, and high signal intensity on T2-weighted imaging/DW-MRI) for hemangiomas and malignant tumors. This is the main reason for radiological and clinical misdiagnosing hemangiomas as malignant tumors. So hemangiomas were classified out as a separate group in this study. IVIM MR imaging has been utilized as an attractive noninvasive imaging technique with the potential for assessing both tissue perfusion and diffusion of STTs using a single DW imaging.[10,12] And it shows a unique profile of microcirculation and pure molecular diffusion within tumors. Our study showed that the ADCslow and ADCfast values of hemangiomas, BSTTEHs, and STSs were significantly different, which suggested that IVIM imaging facilitates understanding of tumor tissue characteristics of perfusion and diffusion. On the other hand, ADCstandard values of hemangiomas, BSTTEHs, and STSs were also significantly different. The ADCstandard of BSTTEHs was maximum (1.555 ± 0.176 × 10−3 mm2/s), while the ADCstandard of STSs was minimum (1.009 ± 0.177 × 10−3 mm2/s) due to active proliferative capacity of sarcomas. The limitation of water molecular diffusion of malignant tumors leads to the decrease of ADC value.[13] In the bi-exponential model, ADCslow (P = 0.014) was an effective parameter to distinguish hemangiomas from other benign tumors. ADCslow with a high b value (>200 s/mm2) is the true diffusion coefficient of pure water in tumors with perfusion components removed at the same time. There were significant differences for values of ADCslow among hemangiomas, BSTTEHs, and STSs (Table 3). The value of ADCslow decreased from BSTTEHs to STSs with hemangiomas in the middle level. The reason is that potential proliferation of STSs is faster than BSTTs. For STSs, there are large nuclei, less cytoplasm, and a dense array of cells, which lead to the extracellular space reduced, the cell membrane permeability reduced, and the water molecular diffusion limited.[14-17] So ADCslow decreased significantly. According to ROC curve, the cut-off value of ADCslow without perfusion effects is smaller than that of ADCstandard in the bi-exponential of IVIM model. As stated above, ADCslow may be a meaningful parameter for differential diagnosis of hemangiomas, BSTTEHs, and STSs. Microcirculation perfusion, namely fast moving component in the bi-exponential of IVIM model, is more sensitive to the MR signal attenuation.[18] According to the bi-exponential theory, ADCfast is closely related to microvessel density of tumor tissues at low b value (<200 s/mm2). In this study, ADCfast was significantly greater than related ADCslow. It means that ADCfast is sensitive to MR signal attenuation at lower b values. There is a maximum value of ADCfast of STSs as the same results of report[12] about ADCfast for different groups (cervical tumor, myometrium, and leiomyoma), which confirmed ADCfast associated with the degree of tissue microvessel perfusion. The fractional volume of capillary blood flowing in each voxel is measured using f.[19] f value may correlate with the amount of normal angiogenesis with intact vessels in terms of basement membrane thickness and pericyte coverage, and it increases with the augmented tissue perfusion components.[20] Our results suggest that hemangiomas (0.682 ± 0.060) are rich in capillaries per unit tumor volume, while STSs (0.503 ± 0.068) are relatively poor in capillaries because liposarcomas and extraskeletal myxoid chondrosarcomas are not rich in blood vessels. Therefore, f value may be an indicator of intact vascular permeability. There are several limitations in this research. First of all, a major limitation of the present study was the small patient cohort of different STTs. Furthermore, IVIM imaging is sensitive to little movement, which may be problematic for thigh IVIM imaging due to pulsation of arteries. Lastly, this study was only to screen out hemangioma from BSTTs, and further research is necessary to differentiate other types of STTs.

CONCLUSION

To our knowledge, this is the first of its kind report about the application of pixel-based IVIM imaging to evaluate heterogeneous STTs. It may provide useful information to discriminate malignant tumors from benign ones regarding patient stratification and strategy in further treatment.
  20 in total

Review 1.  Radiologic evaluation of soft-tissue masses: a current perspective.

Authors:  M J Kransdorf; M D Murphey
Journal:  AJR Am J Roentgenol       Date:  2000-09       Impact factor: 3.959

2.  The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study.

Authors:  Maïté Lewin; Laetitia Fartoux; Alexandre Vignaud; Lionel Arrivé; Yves Menu; Olivier Rosmorduc
Journal:  Eur Radiol       Date:  2010-08-05       Impact factor: 5.315

3.  Intravoxel incoherent motion perfusion MR imaging: a wake-up call.

Authors:  Denis Le Bihan
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

4.  Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors.

Authors:  Misa Sumi; Marc Van Cauteren; Tadateru Sumi; Makoto Obara; Yoko Ichikawa; Takashi Nakamura
Journal:  Radiology       Date:  2012-03-23       Impact factor: 11.105

5.  Hemangiomas of the fingers: MR imaging evaluation.

Authors:  N H Theumann; J Bittoun; S Goettmann; D Le Viet; A Chevrot; J L Drapé
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

6.  Perfusion and diffusion characteristics of cervical cancer based on intraxovel incoherent motion MR imaging-a pilot study.

Authors:  Elaine Yuen Phin Lee; Xue Yu; Mandy Man Yee Chu; Hextan Yuen Sheung Ngan; Steven Wai Kwan Siu; Inda Sung Soong; Queenie Chan; Pek-Lan Khong
Journal:  Eur Radiol       Date:  2014-04-19       Impact factor: 5.315

7.  Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging.

Authors:  D Le Bihan; R Turner; J R MacFall
Journal:  Magn Reson Med       Date:  1989-06       Impact factor: 4.668

Review 8.  Emerging therapies for adult soft tissue sarcoma.

Authors:  Stefano Radaelli; Sivia Stacchiotti; Paolo G Casali; Alessandro Gronchi
Journal:  Expert Rev Anticancer Ther       Date:  2014-02-20       Impact factor: 4.512

9.  Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters--a pilot study.

Authors:  Hadrien A Dyvorne; Nicola Galea; Thomas Nevers; M Isabel Fiel; David Carpenter; Edmund Wong; Matthew Orton; Andre de Oliveira; Thorsten Feiweier; Marie-Louise Vachon; James S Babb; Bachir Taouli
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

10.  MR imaging of the musculoskeletal soft tissue mass: is heterogeneity a sign of malignancy?

Authors:  Kwok Kuen Pang; Tudor Hughes
Journal:  J Chin Med Assoc       Date:  2003-11       Impact factor: 2.743

View more
  7 in total

1.  A preliminary exploration of the intravoxel incoherent motion applied in the preoperative evaluation of mediastinal lymph node metastasis of lung cancer.

Authors:  Xin Ye; Shuo Chen; Yaru Tian; Bin You; Wenqian Zhang; Yan Zhao; Tao Jiang; Bin Hu; Hui Li
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  Tumor spatial heterogeneity in myxoid-containing soft tissue using texture analysis of diffusion-weighted MRI.

Authors:  Hyun Su Kim; Jae-Hun Kim; Young Cheol Yoon; Bong Keun Choe
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

3.  Comparison Between 3-Scan Trace and Diagonal Body Diffusion-Weighted Imaging Acquisitions: A Phantom and Volunteer Study.

Authors:  Stefanie J Hectors; Mathilde Wagner; Idoia Corcuera-Solano; Martin Kang; Alto Stemmer; Michael A Boss; Bachir Taouli
Journal:  Tomography       Date:  2016-12

4.  Diagnostic Performance of Diffusion MRI for differentiating Benign and Malignant Nonfatty Musculoskeletal Soft Tissue Tumors: A Systematic Review and Meta-analysis.

Authors:  Qian Wang; Xinguang Xiao; Yanchang Liang; Hao Wen; Xiaopeng Wen; Meilan Gu; Cuiping Ren; Kunbin Li; Liangwen Yu; Liming Lu
Journal:  J Cancer       Date:  2021-10-28       Impact factor: 4.207

5.  Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to predict early response to anti-tumor therapy in advanced non-small cell lung cancer (NSCLC): a comparison of intravoxel incoherent motion-derived parameters and apparent diffusion coefficient.

Authors:  Zheng Yuan; Xiao-Min Niu; Xue-Mei Liu; Hong-Chao Fu; Ting-Jia Xue; Chi Wan Koo; Katsuhiro Okuda; Feng Yao; Xiao-Dan Ye
Journal:  Transl Lung Cancer Res       Date:  2021-08

6.  Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness.

Authors:  Sean D McGarry; Michael Brehler; John D Bukowy; Allison K Lowman; Samuel A Bobholz; Savannah R Duenweg; Anjishnu Banerjee; Sarah L Hurrell; Dariya Malyarenko; Thomas L Chenevert; Yue Cao; Yuan Li; Daekeun You; Andrey Fedorov; Laura C Bell; C Chad Quarles; Melissa A Prah; Kathleen M Schmainda; Bachir Taouli; Eve LoCastro; Yousef Mazaheri; Amita Shukla-Dave; Thomas E Yankeelov; David A Hormuth; Ananth J Madhuranthakam; Keith Hulsey; Kurt Li; Wei Huang; Wei Huang; Mark Muzi; Michael A Jacobs; Meiyappan Solaiyappan; Stefanie Hectors; Tatjana Antic; Gladell P Paner; Watchareepohn Palangmonthip; Kenneth Jacobsohn; Mark Hohenwalter; Petar Duvnjak; Michael Griffin; William See; Marja T Nevalainen; Kenneth A Iczkowski; Peter S LaViolette
Journal:  J Magn Reson Imaging       Date:  2021-11-12       Impact factor: 5.119

7.  Multi-scale segmentation in GBM treatment using diffusion tensor imaging.

Authors:  Roushanak Rahmat; Khadijeh Saednia; Mohammad Reza Haji Hosseini Khani; Mohamad Rahmati; Raj Jena; Stephen J Price
Journal:  Comput Biol Med       Date:  2020-05-22       Impact factor: 4.589

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.